Bluejay Diagnostics raises $4.5M in private placement of stock and warrants

Bluejay Diagnostics, Inc.

Gross proceeds of $4.5M; net proceeds ~$4.0M after 8% placement agent fee and expenses.
Issued 2.25M shares/pre-funded warrants at $2.00/unit plus Series F warrants for 4.5M shares at $1.75.
Net proceeds to fund FDA approval efforts, clinical studies, R&D, and working capital.
Rodman & Renshaw acted as exclusive placement agent; warrants include 4.99%/9.99% beneficial ownership caps.
Company agreed to file resale registration statement by Oct 24, 2025, and has 90-day issuance lock-up post-effectiveness.

item 1.01item 3.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.